Google has signed up a high-profile collaborator to work on its burgeoning cloud genomics platform. The agreement will see the Broad Institute of MIT and Harvard work with Google to create new tools that pair their respective strengths in data analysis and cloud computing, starting with the offering of GATK as a service.
Google has revealed its pitch to establish wearables as a cornerstone of clinical trials. The wristband health tracker is aimed squarely at the clinical trial and healthcare sectors, setting it apart from consumer-focused rivals from Apple and Fitbit.
Google is teaming up with The Broad Institute of MIT and Harvard to create new ways of sharing genomic data and reduce barriers associated with storing and processing genetic information.
Google Genomics is partnering with the Broad Institute to address some of the infrastructural issues around storing huge data sets as well as developing new tools needed to analyze the data and come up with some new directions on human health and treatments.
Oxford Sciences Innovation (OSI) has eased past its £300 million ($475 million) fundraising target. The University of Oxford-focused investment vehicle pulled in a total of £320 million after Google's VC wing contributed to a fundraising drive that had already attracted Neil Woodford and other big names in British biotech.
Google has not wasted any time since launching its life sciences division group a couple of years ago, sinking funds into med tech projects to expand its reach in wearable health. Now the company is charging full speed ahead with one of its initiatives, developing a health-tracking wristband device with its eye on FDA approval.
The battlefront between Amazon and Google covers a diverse range of fields, from online search and advertising, to smartphones and shopping. Increasingly, genomics is emerging as another hotspot, with both companies scrambling to establish themselves as the place to store and analyze DNA data.
A group of UC Berkeley investigators engaged in slowing down the aging process say they obtained some promising results in targeting a key culprit implicated in weakening tissues throughout the body.
Google's Baseline study is getting a boost, with a Harvard cardiologist moving over to lead the initiative almost a year after the company revealed its plans to aggregate molecular and genetic data to jump-start medical research.
Google's stealthy biotech Calico is setting up shop inside the Buck Institute for Research on Aging in Novato, CA, after hammering out the latest in a long lineup of deals to collaborate on a new generation of therapeutics.